2,773
edits
Psychedelics: Difference between revisions
m
no edit summary
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
<seo title="Psychedelic Medicine" metakeywords="psychedelic drugs list, psychedelic drugs for depression, psychedelic drugs australia, psychedelic drugs literature, psychedelic plant medicine, psychedelic drug used to treat ptsd, psychedelic drug used for depression" metadescription="What is psychedelic medicine?"/> | <seo title="Psychedelic Medicine" metakeywords="psychedelic drugs list, psychedelic drugs for depression, psychedelic drugs australia, psychedelic drugs literature, psychedelic plant medicine, psychedelic drug used to treat ptsd, psychedelic drug used for depression" metadescription="What is psychedelic medicine?"/> | ||
[[File:Psychedelic effect.jpg|alt=This figure is from a 2014 study in the Journal of the Royal Society Interface. The image on the left is of a human brain on a placebo, and the image on the right is of a brain on psilocybin.|thumb|'''Figure 1'''. A 2014 study in the ''Journal of the Royal Society Interface''. The image on the left is of a human brain on a placebo, and the image on the right is of a brain on a psychedelic.]] | [[File:Psychedelic effect.jpg|alt=This figure is from a 2014 study in the Journal of the Royal Society Interface. The image on the left is of a human brain on a placebo, and the image on the right is of a brain on psilocybin.|thumb|'''Figure 1'''. A 2014 study in the ''Journal of the Royal Society Interface''. The image on the left is of a human brain on a placebo, and the image on the right is of a brain on a psychedelic.]] | ||
'''Psychedelics are [[Drugs|medicinal compounds]] that given the correct [[priming]] (set) and [[setting]] have potent anxiolytic, antidepressant and anti addictive effects.''' In some countries they are classified as illegal, however, with the advent of the psychedelic renaissance the taboo is lifting leading to countries decriminalising and patients gaining access via [[Medical Tourism|medical tourism]]. | '''Psychedelics are [[Drugs|medicinal compounds]] that given the correct [[priming]] (set) and [[setting]] have potent anxiolytic, antidepressant and anti addictive effects.''' In some countries they are classified as illegal, however, with the advent of [[The Psychedelic Renaissance|the psychedelic renaissance]] the taboo is lifting leading to countries decriminalising and many patients gaining access via [[Medical Tourism|medical tourism]]. | ||
During the [[Psychedelic Experience|psychedelic experience,]] as shown in the illustrated brain scan to the right ('''Figure 1''') parts of the brain which do not usually communicate with one another start talking, and subconscious inputs open up to the conscious mind. The experience is thought to open a [[Neuroplasticity|neuroplastic]] window giving users an opportunity to correct ruminating thought patterns thought to be the basis of [[Mental Illness|mental illnesses]] such as bipolarity<ref>'''Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption'''. Emma Morton, Kimberly Sakai, and Josh Woolley. Volume 37, Issue . <nowiki>https://doi.org/10.1177/02698811221131997</nowiki>. Accessed 23 Jan 2023 via https://journals.sagepub.com/doi/full/10.1177/02698811221131997</ref>, [[depression]], anxiety. | During the [[Psychedelic Experience|psychedelic experience,]] as shown in the illustrated brain scan to the right ('''Figure 1''') parts of the brain which do not usually communicate with one another start talking, and subconscious inputs open up to the conscious mind. The experience is thought to open a [[Neuroplasticity|neuroplastic]] window giving users an opportunity to correct ruminating thought patterns thought to be the basis of [[Mental Illness|mental illnesses]] such as bipolarity<ref>'''Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption'''. Emma Morton, Kimberly Sakai, and Josh Woolley. Volume 37, Issue . <nowiki>https://doi.org/10.1177/02698811221131997</nowiki>. Accessed 23 Jan 2023 via https://journals.sagepub.com/doi/full/10.1177/02698811221131997</ref>, [[depression]], anxiety. | ||